Compare Range Nuclear Renaissance ETF (NUKZ) vs Relay Therapeutics Inc. Common Stock (RLAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Range Nuclear Renaissance ETF vs Relay Therapeutics Inc. Common Stock — how do they compare? Range Nuclear Renaissance ETF trades at $61.26 (market cap $698.21M), while Relay Therapeutics Inc. Common Stock trades at $17.88 (market cap $3.82B). The key difference: Relay Therapeutics Inc. Common Stock is far larger — about 5.5× Range Nuclear Renaissance ETF's market cap, and Relay Therapeutics Inc. Common Stock is trading nearer its 52-week high, Range Nuclear Renaissance ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Range Nuclear Renaissance ETF for 18 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.
| NUKZ | RLAY | |
|---|---|---|
Market Cap | $698.21M | $3.82B |
Volume | 57,444 | 4,332,079 |
Sector | Sector/Thematic | Health |
52-Week High | $76.23 | $20.75 |
52-Week Low | $60.23 | $6.03 |
Typical Hold Time | 18 Days | 0 Days |
Enterprise Value | — | $2.93B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Range Nuclear Renaissance ETF
Range Nuclear Renaissance ETF seeks to track companies related to the nuclear energy industry. Its holdings may include businesses involved in uranium, nuclear power generation, reactors, and nuclear services.
Read more on NUKZ →About Relay Therapeutics Inc. Common Stock
Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →
